Donald Trump's election night speech underscored Elon Musk, CEO of Tesla (TSLA, Financial), as one of the major beneficiaries alongside Trump himself. Trump praised Musk, highlighting his significant contributions to conservative political ventures and SpaceX's potential government contracts.
Trump commended Musk's SpaceX and its satellite network Starlink. With Trump in office, Musk could see reduced regulatory pressures and increased opportunities for federal contracts. SpaceX and Tesla have historically secured substantial government contracts, totaling at least $15.4 billion in the past decade.
The partnership with Trump aligns with Musk's longstanding criticism of regulatory oversight. Musk's backing of Trump suggests a strategic move to secure his businesses against regulations and garner governmental support.
Tesla (TSLA, Financial) could benefit as Musk influences federal automotive safety regulations and lobbies against electric vehicle tax credit policies. After Trump's victory speech, Tesla's stock surged by 15%.
SpaceX could see eased regulations under Trump's efficiency department proposal, benefiting rocket launches. Starlink, under a new FCC leadership suggested by Trump, could receive favorable terms for rural broadband initiatives.
For his social media venture X, Musk confronted FTC issues post-Twitter acquisition, expressing intent to improve privacy compliance. His friction with the FTC may ease with a Trump administration reshaping regulatory leadership.
Musk's AI startup, xAI, seeks to shield against excessive AI regulations, potentially influencing new AI guidelines under Trump. In California, Musk controversially supports AI regulation, balancing innovation concerns with regulatory needs.
The Boring Company faces regulatory hurdles for its transportation projects. With governmental allies, it may achieve greater success in infrastructure projects.
Neuralink, Musk's brain-interface tech company, could benefit from streamlined FDA processes under Musk's broader vision of governmental efficiency, expediting approvals for medical devices.
